About
Cancer Treatments
Areas of Focus
Categories
Small Molecule Pharmaceutical
Clinical Trials (10)
View allTotal Trials
10
As Lead Sponsor
10
As Collaborator
0
Total Enrollment
905
By Phase
PHASE1: 2PHASE3: 2PHASE2: 3PHASE1/PHASE2: 2
By Status
TERMINATED: 7WITHDRAWN: 1COMPLETED: 1APPROVED_FOR_MARKETING: 1
Clinical Trials Pipeline9 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT04918511Lead Sponsor
A Study of OPD5 Followed by Autologous Stem Cell Transplant for Patients With Relapsed Refractory Multiple Myeloma
PHASE1Withdrawn
Started: May 27, 2021 · Completed: Dec 31, 2025
NCT04649060Lead Sponsor
Study of Melflufen (Melphalan Flufenamide) in Combination With Daratumumab in Relapsed-Refractory Multiple Myeloma
PHASE3Terminated
54 participants
Started: Dec 21, 2020 · Completed: Feb 7, 2022
NCT04115956Lead Sponsor
A Clinical Study of Melphalan Flufenamide (Melflufen) and Dexamethasone for Patients With Immunoglobulin Light Chain (AL) Amyloidosis
PHASE1Terminated
6 participants
Started: Aug 6, 2020 · Completed: Jan 5, 2022
NCT04412707Lead Sponsor
A PK, Safety and Tolerability Study of Peripheral and Central Infusion of Melflufen in RRMM Patients
PHASE2Terminated
27 participants
Started: Aug 4, 2020 · Completed: Jan 10, 2022
NCT03639610Lead Sponsor
PK of Melphalan During Treatment With Melflufen and Dexamethasone in Patients With RRMM and Impaired Renal Function
PHASE2Terminated
35 participants
Started: Aug 28, 2018 · Completed: Dec 22, 2021
Locations (1)
Headquarters
Stockholm, Sweden
Map
Loading map...